Chagas Disease is a parasitic disease caused by coming in contact with the feces of an infected triatomine bug. It can also be caused organ transplant and blood transfusions from infected donors. The bug is common in areas with poor housing; thus, there is an endemic in Central and South America. Chagas Disease is most common in children and starts in an acute stage. During this stage, symptoms can be unnoticeable, but can include fever, rash, and headache. The acute stage last from a few weeks to a few months and then transitions to the chronic stage. The symptoms of chronic Chagas Disease are irregular heartbeat, congestive heart failure, and difficulty swallowing. When in the acute stage, Chagas Disease can be treated with medications that focus on killing the parasite. During the chronic stage, it cannot be treated with medications, but the symptoms of Chagas disease can be treated by targeting that specific problem.
Chagas Disease Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Chagas Disease below!
For more information on how to use Laverne, please read the How to Guide.
We have 4119 products for the study of Chagas Disease that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Chagas Disease is also known as chagas disease, chagas' disease with digestive system involvement, chagas' disease with nervous system involvement, chagas' disease with other organ involvement, south american trypanosomiasis, new world trypanosomiasis, american trypanosomiasis, chagas' disease.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.